Id |
Subject |
Object |
Predicate |
Lexical cue |
T692 |
0-38 |
Sentence |
denotes |
Experimental Model and Subject Details |
T693 |
40-45 |
Sentence |
denotes |
Cells |
T694 |
46-398 |
Sentence |
denotes |
African green monkey kidney epithelial Vero E6 (Vero 76, clone E6, Vero E6, ATCC® CRL-1586) authenticated by ATCC and tested negative for mycoplasma contamination prior to commencement were maintained in a humidified atmosphere at 37°C with 5% CO2, in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS, Invitrogen). |
T695 |
399-499 |
Sentence |
denotes |
ACE2-expressing A549 cells, a human lung epithelial cell line, were a kind gift from Brad Rosenberg. |
T696 |
500-599 |
Sentence |
denotes |
A549-ACE2 cells were cultured in DMEM supplemented with 10% FBS and maintained at 37°C with 5% CO2. |
T697 |
600-747 |
Sentence |
denotes |
Caco-2 (ATCC® HTB-37) human colon epithelial cells were maintained in a humidified atmosphere at 37°C with 5% CO2 in DMEM-containing 20% (v/v) FBS. |
T698 |
749-782 |
Sentence |
denotes |
Viruses (Institut Pasteur, Paris) |
T699 |
783-964 |
Sentence |
denotes |
The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 was supplied by the National Reference Centre for Respiratory Viruses hosted by Institut Pasteur (Paris, France) and headed by Pr. |
T700 |
965-985 |
Sentence |
denotes |
Sylvie van der Werf. |
T701 |
986-1044 |
Sentence |
denotes |
The isolate originated from a human sample provided by Dr. |
T702 |
1045-1047 |
Sentence |
denotes |
X. |
T703 |
1048-1063 |
Sentence |
denotes |
Lescure and Pr. |
T704 |
1064-1066 |
Sentence |
denotes |
Y. |
T705 |
1067-1119 |
Sentence |
denotes |
Yazdanpanah from the Bichat Hospital, Paris, France. |
T706 |
1120-1208 |
Sentence |
denotes |
The isolate was supplied through the European Virus Archive goes Global (EVAg) platform. |
T707 |
1209-1301 |
Sentence |
denotes |
Viral stocks were prepared by propagation in Vero E6 cells in DMEM supplemented with 2% FBS. |
T708 |
1302-1442 |
Sentence |
denotes |
Viral titers were determined by plaque assay in Minimum Essential Media (MEM) supplemented with 2% (v/v) FBS (Invitrogen) and 0.05% agarose. |
T709 |
1443-1633 |
Sentence |
denotes |
All experiments involving live SARS-CoV-2 were performed in compliance with Institut Pasteur Paris’s guidelines for Biosafety Level 3 (BSL-3) containment procedures in approved laboratories. |
T710 |
1634-1716 |
Sentence |
denotes |
All experiments were performed in at least three biologically independent samples. |
T711 |
1718-1749 |
Sentence |
denotes |
Viruses (Mount Sinai, New York) |
T712 |
1750-2036 |
Sentence |
denotes |
For infection experiments in ACE2-A549 cells, SARS-CoV-2, isolate USA-WA1/2020 (NR-52281), which shares 99.983% sequence identity with the BetaCoV/France/IDF0372/2020 isolate, was deposited by the Center for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH. |
T713 |
2037-2272 |
Sentence |
denotes |
SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS, 4.5 g/L D-glucose, 4 mM L-glutamine, 10 mM Non-Essential Amino Acids, 1 mM Sodium Pyruvate and 10 mM HEPES as described previously (Blanco-Melo et al., 2020). |
T714 |
2273-2519 |
Sentence |
denotes |
All work involving live SARS-CoV-2 was performed in the CDC/USDA-approved BSL-3 facility of the Global Health and Emerging Pathogens Institute at the Icahn School of Medicine at Mount Sinai in accordance with institutional biosafety requirements. |
T715 |
2521-2562 |
Sentence |
denotes |
Viruses (University of Freiburg, Germany) |
T716 |
2563-2728 |
Sentence |
denotes |
For infection experiments in Caco-2 cells, SARS-CoV-2 isolate Muc-IMB-1/2020, kindly provided by the Bundeswehr Institute of Microbiology, Munich, Germany, was used. |
T717 |
2729-2805 |
Sentence |
denotes |
SARS-CoV-2 was propagated in Vero E6 cells in DMEM supplemented with 2% FBS. |
T718 |
2806-3086 |
Sentence |
denotes |
All work involving live SARS-CoV-2 was performed in the BSL-3 facility of the Institute of Virology, University Hospital Freiburg, and was approved according to the German Act of Genetic Engineering by the local authority (Regierungspraesidium Tuebingen, permit UNI.FRK.05.16/05). |